Dr. Comings Publications # 301-400
301. Comings, D.E., Muhleman, D., Ahn, C., Gysin, R., and Flanagan, S.D. The dopamine D2 receptor gene: A genetic risk factor
in substance abuse. Drug and Alcohol Dependence 34: 175-180, 1994.
302.
Legro, R., Dietz, G., Comings, D.E., and Kovacs, B.W.. Association of D2 receptor gene haplotypes with anovulation and fecundity
in female Hispanics. Human Reproduction 9: 1271-1275, 1994.
303. Comings, D.E. Tourette’s syndrome and psychiatric disorders. Brit. J. Psychiat. 166:399, 1995.
304. Comings, D.E. Letter to editor, DSM-IV Criteria for Tourette’s. J.Am.Acad.Child.Adolesc.Psy. 34:401-402, 1995.
305. Comings, D.E., Wu, S., Chiu, H., Ring, R.H., Ahn, C., Muhleman, D., Dietz, G., and Gade, R. Polygenic inheritance at a Molecular
Level: The additive effect of Three Dopaminergic Genes in Tourette Syndrome, ADHD, and Conduct Disorder. American
Society of Human Genetics meeting, Minneapolis, Minnesota, 1995. Abstract
306. Blum, K., Sheridan, P.J., Wood, R.C., Sheridan, P.J., Braverman, E.R., Chen, T.J.H.., and Comings, D.E. Dopamine D2 receptor
gene variants: Association and linkage studies in impulsive, addictive and compulsive disorders.
Pharmacogenetics 5: 121-141, 1995.
307. Comings, D. E. The Dopamine D2 receptor and Tourette syndrome. Arch.Neurol. 52: 441-442, 1995.
308. Comings, D. E. The Role of genetic factors in depression. Am.J.Med.Gen.(Neuropsych.Genet.) 60: 111-121, 1995.
309. Comings, D. E. The haplotype relative risk technique lacks power in polygenic inheritance.
1995 World Congress Psychiatric Genetics 5:103, 1995.
310. Comings, D. E. IQ and drug abuse. 1995 World Congress Psychiatric Genetics 5: 76, 1995.
311. Comings, D. E. Polygenic inheritance of psychiatric disorders: A hypothesis. 1995 World Congress Psychiatric Genetics 5: S48, 1995.
312. Comings, D. E., Muhleman, D., Dietz, G., Gade, R., C. Chiu, S. Wu, and MacMurray, J.,. Sequence and polymorphism studies of the
human tryptophan 2,3-dixoygenase (TDO2) gene. 1995 World Congress Psychiatric Genetics 5: S99, 1995.
313. Comings, D. E., H. Wu, C. Chiu, R. S. Ring, C. Ahn, Muhleman, D., Dietz, G., and Gade, R.,. Polygenic inheritance of Tourette
syndrome (TS) and ADHD: The additive effect of three dopaminergic genes. 1995 World Congress Psychiatric Genetics
5: S99, 1995.
314. Comings, D. E., Muhleman, D., C. Chiu, Dietz, G., and Gade, R.,. Dopamine D2 receptor gene in Tourette syndrome (TS).
1995 World Congress Psychiatric Genetics 5: S98, 1995.
315. Comings, D. E., Chiu, C., Muhleman, D., and MacMurray., J. Genetic studies of the dopamine ß-hydroxylase (DβH) gene in impulse
disorders and learning problems. 1995 World Congress Psychiatric Genetics 5: S86, 1995.
316. Ring, R. H. and Comings, D.E.,. Dopamine transporter gene (DAT1) in Tourette syndrome and autism.
1995 World Congress Psychiatric Genetics 5: S87, 1995.
317. Comings, D. E. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their
relatives. J.Dev.Behav.Pediatr. 16: 142-157, 1995.
318. Comings, D. E. Sexual expression, genetics, and testosterone in Tourette syndrome - response.
Am.J.Med.Gen.(Neuropsych.Genet.) 60: 594, 1995.
319. Comings, D. E. Tourette Syndrome: A Behavioral Spectrum Disorder. In: Behavioral Neurology of Movement Disorders,
ed. Weiner, W. J. and Lang, A.E. Raven Press, NY, pp.293-303, 1995
320. Comings, D. E. Tourette syndrome: A hereditary neuropsychiatric spectrum disorder. Ann.Clin.Psychiatry 6: 235-247, 1995.
321. Comings, D. E., MacMurray, J., Johnson, P., Dietz, G., and Muhleman, D. Dopamine D2 Receptor Gene (DRD2) Haplotypes and the
Defense Style Questionnaire in Substance Abuse, Tourette Syndrome and Controls . Biol.Psychiatry 37: 798-805, 1995.
322. Comings, D. E., Muhleman, D., Gietz, G., Sherman, M., and Forest, G. Sequence of human tryptophan 2,3-dioxygenase: Presence of
a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat.
Genomics 29: 390-396, 1995.
323. Legro, R. S., Muhleman, D., Comings, D.E., R. A. Lobo, and B. W. Kovacs. A dopamine D3 receptor genotype is associated with
hyperandrogenic chronic anovulation and resistance to ovulation induction with clomiphene citrate.
Fertility and Sterility 63: 779-784, 1995.
324. Blake, H., Gade, R., S. Wu, Muhleman, D., MacMurray, J., J. Johnson, R. Verde, and D. Comings. An association between the
dopamine-β-hydroxylase dinculeotide repeat polymorphism and drug abuse patterns. Psychiat.Genet. 6: 160, 1996.
325. Blum, K., J. G. Cull, E. R. Braverman, and Comings, D.E.,. Reward Deficiency Syndrome. American Scientist 84: 132-145, 1996.
326. Blum, K., PL. Sheridan, R. C. Wood, E. R. Braverman, J. H. Chon, J. G. Gull, and Comings, D.E. The D2 dopamine receptor gene
as determinant of reward deficiency syndrome. J.R.Soc.Med. 89: 396-400, 1996.
327. Boghosiansell, L., Comings, D.E., and J. Overhauser. Tourette syndrome in a pedigree with a 7:18 translocation: identification of a
YAC spanning the translocation breakpoint at 18q22.3. Am.J.Hum.Genet. 59: 999-1005, 1996.
328. Comings, D. E. Both genes and environment play a role in antisocial behavior. Politics and the Life Sciences 15: 84-86, 1996.
329. Comings, D. E. The Gene Bomb. Does higher education and advanced technology accelerate the selection of genes for learning
disorders, ADHD, addictive, and disruptive behaviors? Duarte, CA, Hope Press. 1996. (Book)
330. Comings, D. E. Genetic factors in drug abuse and dependence. In Gordon, H. W. and M. D. Glantz, eds. Individual Differences in the
Biobehavioral Etiology of Drug Abuse. Washington, D.C., National Institut on Drug Abuse. 1996, 16-38.
331. Comings, D. E. Polygenetic inheritance of psychiatric disorders. In Blum, K., E. P. Noble, R. S. Sparks, and P. J. Sheridan, eds.
Handbook of Psychiatric Genetics. Boca Raton,FL, CRC Press. 1996, 235-260.
332. Comings, D. E. Polygenic inheritance and minisatellites. Psychiat.Genet. 6: 157-158, 1996.
333. Comings, D. E. Search for the Tourette Syndrome and Human Behavior Genes. Hope Press. 1996. (Book)
334. Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., and Muhleman, D. The Dopamine D2 Receptor (DRD2)
Gene: A Genetic Risk Factor in Smoking. Pharmacogenetics 6: 73-79, 1996.
335. Comings, D. E., Gade, R., MacMurray, J., Muhleman, D., Johnson, J., Verde, R. and Peters, W. Association of OB gene with obesity,
depression and anxiety in young women. American Society of Human Genetics Meeting, San Francisco, California (Abstract)
Psychiat.Genet. 6: 166, 1996.
336. Comings, D. E., Gade, R., Muhleman, D., and MacMurray, J.,. Role of the HTR1A serotonin receptor gene in Tourette syndrome and
conduct disorder. Psychiat.Genet. 6: 166, 1996.
337. Comings, D. E., Gade, R., S. Wu, C. Chiu, Dietz, G., Muhleman, D., G. Saucier, L. Ferry, R. Burchette, P. Johnson, R. Verde, and
MacMurray, J.,. Dopamine D1 receptor gene and addictive behaviors. Psychiat.Genet. 6: 158, 1996.
338. Comings, D. E., Gonzalez, N., Muhleman, D., MacMurray, J., J. Johnson, and R. Verde. Associations between the 5HT-2R gene and
psychiatric symptoms in substance abusers and controls. Psychiat.Genet. 6: 158, 1996.
339. Comings, D. E., MacMurray, J. P., Gade, R., Muhleman, D., and W. R. Peters. Genetic variants of the human obesity gene:
Association with psychiatric symptoms and body mass index in young women, and interaction with the
dopamine D2 receptor gene. Molecular Psychiatry 1: 325-335, 1996.
340. Comings, D. E., Muhleman, D., Gade, R., C. Chiu, H. Wu, Dietz, G., E. Winn-Dean, L. Ferry, R. J. Rosenthal, H. R. Lesieur, L.
Rugle, J. Sverd, P. Johnson, and J. P. MacMurray. Exon and intron mutations in the human
tryptophan 2,3-dioxygenase gene and their potential association with Tourette syndrome, substance abuse
and other psychiatric disorders. Pharmacogenetics 6: 307-318, 1996.
341. Comings, D. E., Muhleman, D., and R. Gysin. The dopamine D2 receptor (DRD2) gene and susceptibility in posttraumatic stress
disorder: A study and replication. Biol.Psychiatry 40: 368-372, 1996.
342. Comings, D. E., Muhleman, D., J. Johnson, Gade, R., R. Verde, G. Saucier, and MacMurray, J.,. Cannabinoid receptor gene (CNR1)
association with ERP P300 wave amplitude and drug dependence. Psychiat.Genet. 6: 159, 1996.
343. Comings, D. E., R. J. Rosenthal, H. R. Lesieur, L. Rugle, Muhleman, D., C. Chiu, Dietz, G., and Gade, R.,. A study of the dopamine
D2 receptor gene in pathological gambling. Pharmacogenetics 6: 223-234, 1996.
344. Comings, D. E., H. Wu, C. Chiu, R. H. Ring, Dietz, G., and Muhleman, D. Polygenic inheritance of Tourette syndrome, stuttering,
ADHD, conduct and oppositional defiant disorder: The Additive and Subtractive Effect of the three dopaminergic genes -
DRD2, DβH and DAT1. Am.J.Med.Gen.(Neuropsych.Genet.) 67: 264-288, 1996.
345. Comings, D. E., J. Wu, C. Chiu, Muhleman, D., and J. Sverd. Studies of c-Harvey-Ras gene in psychiatric disorders.
Psychiatry Res. 63: 25-32, 1996.
346. Dietz, G., Muhleman, D., MacMurray, J., J. Johnson, R. Verde, and D. Comings. An association between the neuronal nitric oxide
synthase gene (nNOS1a) and Aggressive behavior. Psychiat.Genet. 6: 159, 1996.
347. Gade, R., Blake, H., MacMurray, J., Muhleman, D., J. Johnson, R. Verde, and D. Comings. Relationship of the GABRB3 gene to
adult ADHD and personality traits in Caucasian and African-American samples. Psychiat.Genet. 6: 164-165, 1996.
348. Gade, R., Muhleman, D., MacMurray, J., and D. Comings. Monoamine oxidase gene variants in Tourette syndrome and drug abuse.
Psychiat.Genet. 6: 168, 1996.
349. Lam, S., Y. Shen, T. Nguyen, T. Messier, M. Brann, D. Comings, S. R. George, and B. F. O'Dowd. A serotonin receptor gene
(5HT1A) variant found in a Tourette's syndrome patient. Biochem.Biophys.Res.Comm. 219: 853-858, 1996.
350. MacMurray, J., G. Saucier, Muhleman, D., Gade, R., C. Chiu, S. Wu, Blake, H., L. Ferry, J. Johnson, and Comings, D.E.
Polygenic prediction of parity: GABAA-β3 and dopamine DRD4 gene markers. Psychiat.Genet. 6: 161, 1996.
351. Saucier, G., Muhleman, D., Gade, R., S. Wu, C. Chiu, Blake, H., MacMurray, J., and D. Comings. Polygenes associated with
intravenous drug use. Psychiat.Genet. 6: 161, 1996.
352. Blum, K., E. R. Braverman, J. G. Cull, A. Eisenberg, M. Sherman, N. Schnautz, L. Fischer, D. Mathews, and Comings, D.E.
Association of polymorphisms of dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with
schizoid/avoidant behaviors (SAB) and pathological violence (PV). Biol.Psychiatry 42: 296S, 1997.
353. Blum, K., E. R. Braverman, S. Wu, J. G. Cull, T. J. H. Chen, J. GIll, R. Wood, A. Eisenberg, M. Sherman, K. R. Davis, D. Matthews,
L. Fischer, N. Schnautz, W. Walsh, A. A. Pontius, M. Zedar, G. Kaats, and Comings, D.E.,. Association polymorphisms of
dopamine D2 receptor (DRD2), Dopamine transporter (DAT1) with schizoid/avoidant behavors (SAB).
Molecular Psychiatry 2: 239-246, 1997.
354. Comings, D. E. The Gene Bomb [letter to editor]. J.Med.Genet. 34: 876, 1997.
355. Comings, D. E. Genetic aspects of childhood behavioral disorders. Child Psychiatry Human Devel. 27: 139-150, 1997.
356. Comings, D. E. Years of education and age of first childbirth: Evidence that genes associated with learning and related disorders are the
major factor in the timing of childbirth, and that these genes are increasing in frequency.
In: Genetic Influences on Rertility-Related Processes. Edited by NIH and Society for the Study of Social Biology,
Tucson, AZ Dec 3-5, 1997.
357. Comings, D. E., Gade, R., Wu, S., Chiu, C., Dietz, G., Muhleman, D., Saucier, G., Ferry, L., Burchete, R., Johnson, P., Verde, R., and
MacMurray, J.P. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors.
Molecular Psychiatry 2: 44-56, 1997.
358. Comings, D. E. and MacMurray, J.M. Different genes for susceptibility to drug versus alcohol dependence.
Biol.Psychiatry 42: 295S-296S, 1997.
359. Comings, D. E. and MacMurray, J.M. Molecular heterosis: Implications for complex inheritance. Am.J.Hum.Genet. 61: A196, 1997.
360. Comings, D. E. and MacMurray, J.M. Molelcular heterosis:Implications for psychiatric genetics.
Am.J.Med.Gen.(Neuropsych.Genet.) 74: 656, 1997.
361. Comings, D. E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G., and MacMurray, J.Cannabinoid receptor gene (CNR1):
Association with IV drug use. Molecular Psychiatry 2: 161-168, 1997.
362. Dietz, G. and Comings, D.E. A simple restriction endonuclease based test for the dopamine D2 receptor gene (DRD2) haplotypes:
Linkage disequilibrium of the haplotypes with the Taq A1 allele. Psychiat.Genet. 7: 133-135, 1997.
363. Gade-Andavolu, R., MacMurray, J.P., Blake, H., Muhleman, D., Tourtellotte, W., and Comings, D.E. Association of the GABAA A3
receptor gene (GABRA3) and multiple sclerosis. Arch.Neurol. 1997.
364. Johnson, J. P., Muhleman, D., MacMurray, J., Gade, R., Verde, R., Ask, M., Kelly, J., and Comings, D.E. Association between the
cannabinoid receptor gene (CNR1), and the P300 wave of event-related potentials, and drug dependence .
Molecular Psychiatry 2: 169-171, 1997.
365. MacMurray, J., Miller, W. and Comings, D.E. X-linked genes, twinning, and fertility related behavior. In: Genetic Influences on
fertility-related processes. Edited by NIH and Society for the Study of Social Biology, Tucson, Arizona Dec. 3-5, 1997.
366. Miller, W., D. Pasta, MacMurray, J., and Comings, D.E.,. Genetic influences on childbearing motivation: Further testing a theoretical
framework. In Genetic Indluences on Fertility –Related Processes. Edited by NIH and Society for the Study of Social Biology,
Tuscon, AZ Dec 3-5, 1997.
367. Thompson, M., D. J. Vandenbergh, G. Remington, Comings, D.E., S. R. George, G. R. Uhl, and B. F. O'Dowd. Association study of
Tourette syndrome and alcoholism with novel polymorphisms of the dopamine transporter. Soc.Neurosci.Abstr. 1997.
368. Vandenbergh, D. J., M. Thompson, E. Cook, J. Schaeffer, S. George, E. Bendahhou, J. T. You, M. Hazama, D. Comings, B. O'Dowd,
and G. R. Uhl. High conservation of dopamine transporter sequences among human individuals. Am.J.Hum.Genet. 61: A382, 1997.
369. Wu, S., Muhleman, D., and Comings, D.E. PCR amplification of the Taq I B1/B2 polymorphism at intron 5 of the dopamine β-hydroxylase
gene. Psychiat.Genet. 7: 39-40, 1997.
370. Blake, H., MacMurray, J., Gade-Andavolu, R., Wu, S., Muhleman, D., Dietz, G., Johnson, J.P., Saucier, G., and Comings, D.E.
Gender differences in APOE-associated brain weights of Alzheimer's disease cases.
Am.J.Med.Gen.(Neuropsych.Genet.) 81: 554, 1998.
371. Miller, W. B., D. J. Pasta, MacMurray, J., C. Chiu, S. Wu, and Comings, D.E.,. Genetic influences on childbearing motivation: A theoretical
framework and some emperical evidence. In: Advances in Population: Psychosocial Perspectives Vol 3. Edited by LJ Severy,
WB Miller, London, Jessica Kingsley. 1998.
372. Comings, D. E. All alleles are equal, but some alleles are more equal than others. Molecular Psychiatry 3: 212, 1998.
373. Comings, D. E. The molecular genetics of Attention Deficit Hyperactivity Disorder and Tourette Syndrome: Common, hereditary, treatable,
behavioral disorders that are common in a prison population. Academy of Criminal Justice Meeting (abstract) 1998.
374. Comings, D. E. The molecular genetics of pathological gambling. CNS Spectrums 3: 20-37, 1998.
375. Comings, D. E. Polygenic inheritance and micro/minisatellites. Molecular Psychiatry 3: 21-31, 1998.
376. Comings, D. E. Some genetic aspects of human sexual behavior in Males, Females, and Behavior: Toward Biological Understanding.
Edited by L. Ellis New York, Praeger. Pp 1-12, 1998.
377. Comings, D. E. Tourette syndrome and serotonin. J.Serotonin Res. 4: 239-249, 1998.
378. Comings, D. E. Why Different Rules are Required for Polygenic Inheritance: Lessons from Studies of the DRD2 Gene.
Alcohol 16: 61-70, 1998.
379. Comings, D. E., Gade-Andavolu, R., B. S. Gonzalez, S. Wu, Dietz, G., Muhleman, D., and MacMurray, J.,. Multiple additive associations
(MAA) - A powerful method of identifying the genes in polygenic disorders: ADHD, ODD, CD, Alcoholism and pathological
gambling. Am.J.Hum.Genetics 61: A323, 1998.
380. Comings, D. E., Gade-Andavolu, R., Gonzalez, N., S. Wu, Blake, H., and MacMurray, J.,. Norepinephrine genes, ADHD and Learning
disorders. International Congress Psychiatric Genetics, Bonn, Germany. Am.J.Med.Gen.(Neuropsych.Genet.) 81: 548-549, 1998.
381. Comings, D. E., Gade-Andavolu, R., Gonzalez, N., S. Wu, Muhleman, D., Blake, H., Dietz, G., G. Saucier, and MacMurray, J.
Multiple additive associations: A technique for the identification of genes in polygenic disorders. International Congress of Psychiatric
Genetics, Bonn, Germany. Am.J.Med.Gen.(Neuropsych.Genet.) 81: 489, 1998.
382. Comings, D. E., Gade-Andavolu, R., Gonzalez, N., S. Wu, Muhleman, D., Dietz, G., Blake, H., MacMurray, J.P., L. J. Rugle, H. R.
Lesieur, and R. J. Rosenthal. The genetics of pathological gambling: The additive effect of multiple genes. National Council on
Problem Gambling Meeting Las Vegas, NV June: 1998.
383. Comings, D. E., Wu, S., Johnson, J. P., and MacMurray, J. Phenotypic expression of neuronal nicotinic acetylcholine receptor gene
(CHRNA4) in stressed and unstressed subjects. International Congress Psychiatric Genetics, Bonn, Germany.
Am.J.Med.Gen.(Neuropsych.Genet.) 81, 509, 1998.
384. Comings, D. E., S. Wu, and Muhleman, D.,. Androgen receptor gene, conduct disorder and oppositional defiant disorder. International
Congress Psychitric Genetics, Bonn, Germany. Am.J.Med.Gen.(Neuropsych.Genet.) 81: 549-550, 1998.
385. Gade, R., Muhleman, D., MacMurray, J., and Comings, D.E.,. Correlation of length of VNTR alleles at the X-linked MAOA gene and
phenotypic effect in Tourette syndrome and drug abuse. Molecular Psychiatry 3: 50-60, 1998.
386. Johnson, J. P., Dietz, G., Gade-Andavolu, R., Blake, H., Muhleman, D., G. Saucier, MacMurray, J., and Comings, D.E.,. Association of
endopeptidase (CD10NE) dinucleotide repeat polymorphism with anxiety, depression, and P300 amplitude. International Congress of
Psychiatric Genetics, Bonn, Germany. Am.J.Med.Gen.(Neuropsych.Genet.) 81: 524, 1998.
387. MacMurray, J., S. Wu, Muhleman, D., Gade-Andavolu, R., Blake, H., W. Peters, J. P. Johnson, G. Saucier, and Comings, D.E.
Associations between the gamma-interferon gene (INFG3), asthenia, and obesity. Am.J.Med.Gen.(Neuropsych.Genet.) 81: 524, 1998.
388. Thompson, M., Comings, D.E., S. R. George, and B. F. O'Dowd. Mutation screening of the dopamine D1 receptor (DRD1) gene in
Tourette's syndrome patients and alcohol dependent patients. Am.J.Med.Gen.(Neuropsych.Genet.) (in press): 1998.
389. Thompson, M. D., Comings, D.E., Gonzalez, N., T. Hguyen, R. Tyndale, E. Sellers, S. R. George, and B. F. O'Dowd. The serotonin
transporter gene polymorphisms in Tourette's syndrome and alcohol dependence. Am.J.Hum.Genet. Suppl: 1998.
390. Thompson, M. D., Comings, D.E., Gonzalez, N., T. Nguyen, R. Tyndale, E. Sellers, S. R. George, and B. F. O'Dowd. The role of
serotonin transporter gene polymorphisms in Tourette's syndrome and alcohol dependence. Am.J.Hum.Genet. 61: A311, 1998.
391. Wu, S. and Comings, D.E.,. G5644A polymorphism in the interferon-gamma (INFG) gene. Psychiat.Genet. 8: 57, 1998.
392. Blum, K., Braverman, E. R., Lubar, J. F., Lubar, J. O., Cull, J. G., Eisenberg, A., Sherman, M., Comings, D. E., Wise, J. A., and
Monastra, V. Molecular genetic and electrophysiological basis of "Reward Deficiency Syndrome": Risk of substance use disorder in
attention-deficit-hyperactivity disorder probands. Abstract:ASAM Meeting New York, April. 1999.
393. Blum, K., G. Kaats, A. Eisenberg, M. Sherman, K. Davis, Comings, D.E., J. G. Cull, T. H. J. Chen, R. Wood, L. Bucci, J. A. Wise, E. R.
Breaverman, and D. Pullin. Chromium picolinate induces changes in body composition as a functon of the Taq I Dopamine D2 receptor
A2 alleles. J.Amer.College Nutrition submitted: 1999.
394. Comings, D. E. Clinical implications of dopamine D2 receptor gene susceptibility to posttraumatic stress disorder.
Essential Pharmacology 1: 93-104, 1999.
395. Comings, D. E. Letter to the editor: Tourette syndrome a polygenic disorder. CNS Spectrums 4: 14-15, 1999.
396. Comings, D. E. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor
density. Molecular Psychiatry 4: 213-215, 1999.
397. Comings, D. E. SNPs and polygenic disorders: A less gloomy view. Molecular Psychiatry 4: 314-316, 1999.
398. Comings, D. E., Blake, H., Dietz, G., Gade-Andavolu, R., R. Legro, G. Saucier, P. Johnson, R. Verde, and J. P. MacMurray. The
proenkephalin gene (PENK) and opioid dependence. NeuroReport 10: 1133-1135, 1999.
399. Comings, D. E., C. Chen, S. Wu, and Muhleman, D.,. Association of the androgen receptor gene (AR) with ADHD and conduct disorder.
Neuroreport 10: 1589-1592, 1999.
400. Comings, D. E., Dietz.G., and J. P. M. J. P. Johnson. Association of the enkephalinase gene with low amplitude P300 waves.
NeuroReport 10: 2283-2285, 1999.